Related Experiment Video
Updated: Sep 8, 2026

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
Adrenalectomy suppresses insulin secretion from pancreatic islets of ob/ob mice
1Department of Food Science and Human Nutrition, Michigan State University, East Lansing 48824-1224.
Abstract:
The aim of this work was to examine effects of adrenalectomy and intracerebroventricular injection of dexamethasone on insulin secretion from pancreatic islets of ob/ob mice. Female ob/ob and lean mice fed a stock diet were adrenalectomized at 5 wk of age and studied at 8-9 wks of age. Removal of the adrenal glands from ob/ob mice fed a stock diet normalized their plasma insulin concentration, islet size, and essentially normalized insulin secretion from islets incubated in 10 mM glucose. Insulin secretion from islets was, however, not fully normalized when the incubation buffer contained higher concentrations of glucose (20 mM), or acetylcholine, a potentiator of glucose-induced insulin secretion. Within 90 min after intracerebroventricular administration of dexamethasone plasma insulin concentrations were elevated and glucose-induced (10 mM) insulin secretion from isolated islets of adrenalectomized ob/ob mice increased, but dexamethasone was ineffective in lean mice. Regulation of insulin secretion from pancreatic islets of adrenalectomized ob/ob mice remains abnormal even though adrenalectomy normalized plasma insulin concentrations in these mice. Alterations in glucocorticoid-mediated, central nervous system regulation of insulin secretion likely contribute to hyperinsulinemia in ob/ob mice.
Related Concept Videos
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...

